Globus Medical, Inc. (GMED)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | N/A |
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.09 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 84.23 |
| 52 Week Low 3 | 59.37 |
| 50-Day Moving Average 3 | 70.23 |
| 200-Day Moving Average 3 | 74.70 |
Share Statistics
| Avg Vol (3 month) 3 | 503.83k |
| Avg Vol (10 day) 3 | 505.38k |
| Shares Outstanding 5 | 79.03M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 76.59M |
| % Held by Insiders 1 | 0.85% |
| % Held by Institutions 1 | 69.89% |
| Shares Short (Dec. 14, 2021) 4 | 1.03M |
| Short Ratio (Dec. 14, 2021) 4 | 1.72 |
| Short % of Float (Dec. 14, 2021) 4 | 1.31% |
| Short % of Shares Outstanding (Dec. 14, 2021) 4 | 1.01% |
| Shares Short (prior month Nov. 14, 2021) 4 | 782.15k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec. 30, 2020 |
| Most Recent Quarter (mrq) | Sep. 29, 2021 |
Profitability
| Profit Margin | 19.87% |
| Operating Margin (ttm) | 24.35% |
Management Effectiveness
| Return on Assets (ttm) | 8.30% |
| Return on Equity (ttm) | 11.93% |
Income Statement
| Revenue (ttm) | 941.53M |
| Revenue Per Share (ttm) | 9.41 |
| Quarterly Revenue Growth (yoy) | 6.30% |
| Gross Profit (ttm) | 571.58M |
| EBITDA | 299.22M |
| Net Income Avi to Common (ttm) | 187.04M |
| Diluted EPS (ttm) | 1.82 |
| Quarterly Earnings Growth (yoy) | 6.80% |
Balance Sheet
| Total Cash (mrq) | 553.2M |
| Total Cash Per Share (mrq) | 5.45 |
| Total Debt (mrq) | 5.42M |
| Total Debt/Equity (mrq) | 0.32 |
| Current Ratio (mrq) | 8.00 |
| Book Value Per Share (mrq) | 16.93 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 280.2M |
| Levered Free Cash Flow (ttm) | 185.1M |
